1-7 of 7
eltrombopag
Close
Sort by
Journal Articles

Spotlight on eltrombopag in pediatric ITP in China: a long-term observational study in real-world practice

Clinical Trials & Observations
Xiaoling Cheng, LingLing Fu, Jingyao Ma, Hao Gu, Zhenping Chen, Libo Zhao, Xiaoling Wang, Runhui Wu
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3799–3806.
https://doi.org/10.1182/bloodadvances.2020004110
Published: 2021
Journal Articles

Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias

Clinical Trials & Observations
Xing Fan, Ronan Desmond, Thomas Winkler, David J. Young, Bogdan Dumitriu, Danielle M. Townsley, Fernanda Gutierrez-Rodrigues, Jennifer Lotter, Janet Valdez, Stephanie E. Sellers, Ma Evette Barranta, Ruba N. Shalhoub, Colin O. Wu, Maher Albitar, Katherine R. Calvo, Neal S. Young, Cynthia E. Dunbar
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1700–1710.
https://doi.org/10.1182/bloodadvances.2020001657
Published: 2020
Includes: Supplemental data
Journal Articles

Romiplostim for the management of pediatric immune thrombocytopenia: drug development and current practice

Clinical Trials & Observations
Cindy E. Neunert, Melissa J. Rose
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1907–1915.
https://doi.org/10.1182/bloodadvances.2019000279
Published: 2019
Journal Articles

Activity of eltrombopag in severe aplastic anemia

Clinical Trials & Observations
Phillip Scheinberg
Journal: Blood Advances
Blood Adv (2018) 2 (21): 3054–3062.
https://doi.org/10.1182/bloodadvances.2018020248
Published: 2018
Journal Articles

Phenotype description and response to thrombopoietin receptor agonist in DIAPH1 -related disorder

Clinical Trials & Observations
Sarah K. Westbury, Kate Downes, Claire Burney, Maria L. Lozano, Samya G. Obaji, Cheng Hock Toh, Teresa Sevivas, Neil V. Morgan, Wendy N. Erber, Carly Kempster, Samantha F. Moore, Chantal Thys, Sofia Papadia, Willem H. Ouwehand, NIHR BioResource–Rare Diseases, Michael A. Laffan, Keith Gomez, Kathleen Freson, Jose Rivera, Andrew D. Mumford
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2341–2346.
https://doi.org/10.1182/bloodadvances.2018020370
Published: 2018
Includes: Supplemental data
Journal Articles

Eltrombopag for use in children with immune thrombocytopenia

Clinical Trials & Observations
Taylor Olmsted Kim, Jenny Despotovic, Michele P. Lambert
Journal: Blood Advances
Blood Adv (2018) 2 (4): 454–461.
https://doi.org/10.1182/bloodadvances.2017010660
Published: 2018
Journal Articles

Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells

Ayako Aihara, Tomo Koike, Natsuki Abe, Sou Nakamura, Akira Sawaguchi, Takanori Nakamura, Naoshi Sugimoto, Hiromitsu Nakauchi, Taito Nishino, Koji Eto
Journal: Blood Advances
Blood Adv (2017) 1 (7): 468–476.
https://doi.org/10.1182/bloodadvances.2016000844
Published: 2017
Includes: Supplemental data